UnitedHealth Group Incorporated (UNH) Director Gail R. Wilensky Sells 5,600 Shares
UnitedHealth Group Incorporated (NYSE:UNH) Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Shares of UnitedHealth Group Incorporated (NYSE UNH) traded up 0.27% during mid-day trading on Thursday, hitting $198.17. The stock had a trading volume of 2,684,599 shares. The firm has a 50 day moving average price of $194.00 and a 200 day moving average price of $179.23. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $200.44. The firm has a market cap of $191.60 billion, a PE ratio of 23.81 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the previous year, the firm earned $1.96 earnings per share. The business’s revenue was up 7.7% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is currently 35.13%.
TRADEMARK VIOLATION NOTICE: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/09/07/unitedhealth-group-incorporated-unh-director-gail-r-wilensky-sells-5600-shares.html.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Patten & Patten Inc. TN grew its holdings in shares of UnitedHealth Group by 14.2% during the first quarter. Patten & Patten Inc. TN now owns 7,125 shares of the healthcare conglomerate’s stock worth $1,169,000 after buying an additional 885 shares during the last quarter. Barometer Capital Management Inc. grew its holdings in shares of UnitedHealth Group by 37.5% during the first quarter. Barometer Capital Management Inc. now owns 152,900 shares of the healthcare conglomerate’s stock worth $25,077,000 after buying an additional 41,700 shares during the last quarter. Quantitative Systematic Strategies LLC purchased a new position in shares of UnitedHealth Group during the first quarter worth about $331,000. Ledyard National Bank grew its holdings in shares of UnitedHealth Group by 62.7% during the first quarter. Ledyard National Bank now owns 1,103 shares of the healthcare conglomerate’s stock worth $181,000 after buying an additional 425 shares during the last quarter. Finally, Johanson Financial Advisors Inc. purchased a new position in shares of UnitedHealth Group during the first quarter worth about $1,068,000. 86.21% of the stock is currently owned by hedge funds and other institutional investors.
Several research analysts have recently commented on the company. Cowen and Company reissued an “outperform” rating and issued a $220.00 price target (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Morgan Stanley boosted their price target on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a research report on Friday, August 18th. Finally, Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, June 9th. One investment analyst has rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $203.41.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.